Author

Alexia Berkal

OpenAlex ID: A5147006304

Switch to once-weekly, single-tablet islatravir–lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial

2026 · Amy E Colson, Princy N Kumar, et al. · The Lancet · 3

Works count: 1

Citation count: 3

H-index: 1

I10-index: